@misc{indiciae6c4577c5fee9,
  title = {Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer},
  author = {Waks, A. G. and Cohen, O. and Kochupurakkal, B. and Kim, D. and Dunn, C. E. and Buendia Buendia, J. and Wander, S. and Helvie, K. and Lloyd, M. R. and Marini, L. and Hughes, M. E. and Freeman, S. S. and Ivy, S. P. and Geradts, J. and Isakoff, S. and LoRusso, P. and Adalsteinsson, V. A. and Tolaney, S. M. and Matulonis, U. and Krop, I. E. and D'Andrea, A. D. and Winer, E. P. and Lin, N. U. and Shapiro, G. I. and Wagle, N.},
  year = {2019},
  doi = {10.1101/832717},
  url = {https://www.biorxiv.org/content/10.1101/832717v1},
  note = {Source identifier: 10.1101/832717}
}